| Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans M Grazia Roncarolo, S Gregori, M Battaglia, R Bacchetta, K Fleischhauer, ... Immunological reviews 212 (1), 28-50, 2006 | 1590 | 2006 |
| Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells A Hendel, RO Bak, JT Clark, AB Kennedy, DE Ryan, S Roy, I Steinfeld, ... Nature biotechnology 33 (9), 985-989, 2015 | 1166 | 2015 |
| Type 1 T regulatory cells MG Roncarolo, R Bacchetta, C Bordignon, S Narula, MK Levings Immunological reviews 182 (1), 68-79, 2001 | 1165 | 2001 |
| Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production SE Allan, SQ Crome, NK Crellin, L Passerini, TS Steiner, R Bacchetta, ... International immunology 19 (4), 345-354, 2007 | 1121 | 2007 |
| Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells N Gagliani, CF Magnani, S Huber, ME Gianolini, M Pala, P Licona-Limon, ... Nature medicine 19 (6), 739-746, 2013 | 884 | 2013 |
| Reprogramming human T cell function and specificity with non-viral genome targeting TL Roth, C Puig-Saus, R Yu, E Shifrut, J Carnevale, PJ Li, J Hiatt, J Saco, ... Nature 559 (7714), 405-409, 2018 | 750 | 2018 |
| Defective regulatory and effector T cell functions in patients with FOXP3 mutations R Bacchetta, L Passerini, E Gambineri, M Dai, SE Allan, L Perroni, ... The Journal of clinical investigation 116 (6), 1713-1722, 2006 | 634 | 2006 |
| The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs SE Allan, L Passerini, R Bacchetta, N Crellin, M Dai, PC Orban, SF Ziegler, ... The Journal of clinical investigation 115 (11), 3276-3284, 2005 | 605 | 2005 |
| The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells MK Levings, R Bacchetta, U Schulz, MG Roncarolo International archives of allergy and immunology 129 (4), 263-276, 2002 | 578 | 2002 |
| High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. R Bacchetta, M Bigler, JL Touraine, R Parkman, PA Tovo, J Abrams, ... The Journal of experimental medicine 179 (2), 493-502, 1994 | 533 | 1994 |
| Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity F Barzaghi, L Passerini, R Bacchetta Frontiers in immunology 3, 29136, 2012 | 374 | 2012 |
| From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation R Bacchetta, F Barzaghi, MG Roncarolo Annals of the New York Academy of Sciences 1417 (1), 5-22, 2018 | 370 | 2018 |
| Role of regulatory T cells and FOXP3 in human diseases R Bacchetta, E Gambineri, MG Roncarolo Journal of Allergy and Clinical Immunology 120 (2), 227-235, 2007 | 359 | 2007 |
| Tr1 cells: from discovery to their clinical application M Battaglia, S Gregori, R Bacchetta, MG Roncarolo Seminars in immunology 18 (2), 120-127, 2006 | 359 | 2006 |
| Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome C Woellner, EM Gertz, AA Schäffer, M Lagos, M Perro, EO Glocker, ... Journal of Allergy and Clinical Immunology 125 (2), 424-432. e8, 2010 | 335 | 2010 |
| CD4+ T‐regulatory cells: toward therapy for human diseases SE Allan, R Broady, S Gregori, ME Himmel, N Locke, MG Roncarolo, ... Immunological reviews 223 (1), 391-421, 2008 | 307 | 2008 |
| Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3 SE Allan, AN Alstad, N Merindol, NK Crellin, M Amendola, R Bacchetta, ... Molecular Therapy 16 (1), 194-202, 2008 | 284 | 2008 |
| Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines R Bacchetta, C Sartirana, MK Levings, C Bordignon, S Narula, ... European journal of immunology 32 (8), 2237-2245, 2002 | 281 | 2002 |
| CD4+ regulatory T cells: mechanisms of induction and effector function R Bacchetta, S Gregori, MG Roncarolo Autoimmunity reviews 4 (8), 491-496, 2005 | 278 | 2005 |
| The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases MG Roncarolo, S Gregori, R Bacchetta, M Battaglia, N Gagliani Immunity 49 (6), 1004-1019, 2018 | 276 | 2018 |
